Truvestments Capital’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6
| Closed | -$29 | – | 1003 |
|
|
2025
Q1 | $29 | Hold |
6
| – | – | ﹤0.01% | 1015 |
|
|
2024
Q4 | $50 | Hold |
6
| – | – | ﹤0.01% | 1001 |
|
|
2024
Q3 | $65 | Buy |
+6
| New | +$100 | ﹤0.01% | 916 |
|
|
2024
Q2 | – | Sell |
-6
| Closed | -$160 | – | 283 |
|
|
2024
Q1 | $160 | Hold |
6
| – | – | ﹤0.01% | 706 |
|
|
2023
Q4 | $173 | Hold |
6
| – | – | ﹤0.01% | 771 |
|
|
2023
Q3 | $380 | Hold |
6
| – | – | ﹤0.01% | 655 |
|
|
2023
Q2 | $411 | Hold |
6
| – | – | ﹤0.01% | 664 |
|
|
2023
Q1 | $398 | Hold |
6
| – | – | ﹤0.01% | 642 |
|
|
2022
Q4 | $865 | Sell |
6
-1
| -14% | -$141 | ﹤0.01% | 838 |
|
|
2022
Q3 | $1K | Hold |
7
| – | – | ﹤0.01% | 583 |
|
|
2022
Q2 | $1K | Buy |
+7
| New | +$543 | ﹤0.01% | 592 |
|
|
2022
Q1 | – | Sell |
-7
| Closed | -$1K | – | 228 |
|
|
2021
Q4 | $1K | Sell |
7
-3
| -30% | -$708 | ﹤0.01% | 570 |
|
|
2021
Q3 | $3K | Hold |
10
| – | – | ﹤0.01% | 500 |
|
|
2021
Q2 | $4K | Hold |
10
| – | – | ﹤0.01% | 480 |
|
|
2021
Q1 | $4K | Buy |
10
+8
| +400% | +$3.94K | ﹤0.01% | 535 |
|
|
2020
Q4 | $1K | Buy |
+2
| New | +$1.27K | ﹤0.01% | 580 |
|
|
2020
Q3 | – | Sell |
-2
| Closed | -$1K | – | 351 |
|
|
2020
Q2 | $1K | Buy |
+2
| New | +$1.51K | ﹤0.01% | 529 |
|
|
2019
Q4 | – | Sell |
-3
| Closed | -$4K | – | 197 |
|
|
2019
Q3 | $4K | Sell |
3
-1
| -25% | -$1.53K | ﹤0.01% | 592 |
|
|
2019
Q2 | $6K | Hold |
4
| – | – | ﹤0.01% | 589 |
|
|
2019
Q1 | $7K | Buy |
+4
| New | +$7.04K | 0.01% | 554 |
|
|
2018
Q3 | $10K | Buy |
+5
| New | +$10.3K | ﹤0.01% | 627 |
|
Other funds holding BLUE
Truvestments Capital's BLUE Position: Q2 2025 in Review
Truvestments Capital sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 6 shares — an estimated $29 sold.
Truvestments Capital first reported a position in BLUE in Q3 2018 and held it in 21 quarters. The position peaked at $10K in Q3 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Truvestments Capital reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Truvestments Capital sold 6 bluebird bio shares in Q2 2025, an estimated $29.
- Truvestments Capital first reported a position in bluebird bio in Q3 2018 and held it in 21 quarters.
- Truvestments Capital's bluebird bio position peaked at $10K in Q3 2018.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Truvestments Capital's 13F filing for Q2 2025, filed 13 Aug 2025.